| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |